Navigation Links
Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony

LONDON, Jan. 17, 2011 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won multiple awards at the PharmaTimes Annual Awards 2010 ceremony held at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I am very proud of every Chiltern colleague nominated for an award. They put their best forward each and every day for our clients and their dedication to being the best is evident in all they do. These achievements of the award winners reflect Chiltern's commitment to deliver expert, high quality services around the world and I couldn't be happier that they have received the recognition that is so well-deserved."

Chiltern Award WinnersClinical Research Associate of the Year Gold Award: Helen Chester, Chiltern Resourcing Solutions CRA outsourced to Roche

Clinical Research Associate of the Year Silver Award: Dawn Skingle, Sr. Clinical Research Associate

Clinical Research Team of the Year Bronze Award: Daniel Lowman, Sr. Clinical Research Associate, Kate Backhouse, Clinical Research Associate 2, Jonathan Kinnell, Sr. Manager, Clinical Monitoring, Mark Williams, Clinical Trainer, Europe

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information: More Information Contact:Natalie Chong

Susan OjanenChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer ParkwaySlough

Suite 950Berkshire SL1 4AA


USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533Fax: +44 (0) 1753 511 116

Fax: +1 (423) 968 3567Email:


SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products
2. Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
3. European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends
4. Physiotherapy Associates Announces New Multiple Sclerosis Specialty Treatment Program
5. Sales of Revlimid and the Launch of Several Premium-Priced Emerging Therapies Will Drive Robust 7.2 Percent Annual Growth in the Multiple Myeloma Drug Market
6. Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting
7. Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma
8. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
9. 34-Year-Old Alabama Woman Crosses the Finish Line to Join Team COPAXONE® and Raise Awareness about Multiple Sclerosis
10. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
11. New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... India , November 26, 2015 ... --> adds ... Report" and "Investigation Report on China ... and 2021 forecasts data and information ... . ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... , ... According to an article published November 13th on, ... D.C. revolved around the fact that proper dental care, both at-home and in the ... between periodontal disease (more commonly referred to as gum disease) and diabetes. According to ...
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, ... in light of the recent terrorist attacks in Paris, other cities are taking extra ... from reaching U.S. soil. Especially around special events that may be high-profile in nature, ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A team ... ways to treat it. Surviving Mesothelioma has just posted the findings on the ... University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I ... an inventor from Hillside, N.J. "Many people catch diseases simply from sitting on ... will always be protected from germs." , He developed the patent-pending QUDRATECS to ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print ... USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation ... is distributed nationally, through a vast social media strategy and across a network ...
Breaking Medicine News(10 mins):